Changes in Serum Anti-Glycan Antibodies in Crohn's Disease
Author Information
Author(s): Florian Rieder, Rocio Lopez, André Franke, Alexandra Wolf, Stephan Schleder, Andrea Dirmeier, Anja Schirbel, Philip Rosenstiel, Nir Dotan, Stefan Schreiber, Gerhard Rogler, Frank Klebl
Primary Institution: University of Regensburg
Hypothesis
What are the changes in levels and status of anti-glycan antibodies over time in Crohn's disease patients?
Conclusion
The levels of anti-glycan antibodies fluctuate in a subgroup of Crohn's disease patients, but the antibody status remains stable over time.
Supporting Evidence
- Marked changes in immune response were observed in a subgroup of Crohn's disease patients.
- Antibody status remained stable over time despite fluctuations in levels.
- Clinical phenotypes or NOD2 genotypes were not associated with changes in antibody levels.
Takeaway
This study looked at how certain antibodies in the blood of Crohn's disease patients change over time. While some levels went up and down, most patients kept the same antibody status.
Methodology
The study analyzed 859 serum samples from 253 inflammatory bowel disease patients using ELISA to test for various anti-glycan antibodies.
Potential Biases
Potential presence of subclinical complications at the time of sample procurement.
Limitations
The study was conducted at a single university hospital, which may introduce referral bias, and the follow-up samples were taken at arbitrary visits.
Participant Demographics
The cohort included 207 Crohn's disease patients and 46 ulcerative colitis patients, with a mean age of 35.3 years for CD.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website